Recent FDA report on PML
This is a good letter for anyone to read who is taking or thinking of taking tysabri. This documentation provides…
“I second this” : MS patients report improvements in quality of life, reduced fatigue and improved cognition
MS patients report improvements in quality of life, including physical and psychological well-being, as well as reduced fatigue and improved…
Stuart Schlossman
Sustained improvement in physical function and Quality of Life when using Tysabri
April 2010 Below – find some of what was discussed concerning Tysabri at the recent AAN meetings in Toronto. Beneath…
Stuart Schlossman
AAN: No Pregnancy Issues in Early Natalizumab Review
This report is part of a 12-month Clinical Context series. By Ed Susman, Contributing Writer, MedPage TodayPublished: April 13, 2010Reviewed…
Stuart Schlossman
PML update
Information provided by a Tysabri patient (Karen M) in Miami who has no fears Nasdaq.com By Thomas Gryta, Of DOW…
Stuart Schlossman
Biogen Seeks Test for Brain Disease Linked to MS Drug
Biogen Seeks Test for Brain Disease Linked to MS Drug (Update2) Bloomberg.com By Elizabeth Lopatto April 9 (Bloomberg) — Biogen…
Stuart Schlossman
MS Patients Need Backup when Stopping Natalizumab (Tysabri)
Information provided by Karen M in Miami. By Ed Susman, Contributing Writer, MedPage TodayPublished: April 12, 2010Reviewed by Ari Green,…
Stuart Schlossman
Head-to-Head Study Comparing TYRABRI To Copaxone And Rebif
March 26, 2010 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient…
Stuart Schlossman
A study, much needed for determining long term usage of Tysabri®
IN Stuart’s own words, “I believe the purpose of this study is to see if stopping the use of Tysabri…
Stuart Schlossman
The Tysabri® “RESTORE” Study — an Interruption study of medication usage
FOR THOSE in FLORIDA, this study is taking place at Neurological Associates Research. – See information found below on How…
Stuart Schlossman
